X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA DR. DATSONS LABS ALEMBIC PHARMA/
DR. DATSONS LABS
 
P/E (TTM) x 22.3 -10.9 - View Chart
P/BV x 5.3 0.2 3,234.4% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ALEMBIC PHARMA   DR. DATSONS LABS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-18
DR. DATSONS LABS
Mar-14
ALEMBIC PHARMA/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs645126 513.6%   
Low Rs47031 1,520.4%   
Sales per share (Unadj.) Rs166.1133.0 124.9%  
Earnings per share (Unadj.) Rs21.90.2 14,443.5%  
Cash flow per share (Unadj.) Rs27.56.6 416.1%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs117.8128.8 91.4%  
Shares outstanding (eoy) m188.5231.66 595.5%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x3.40.6 570.5%   
Avg P/E ratio x25.5516.1 4.9%  
P/CF ratio (eoy) x20.311.8 171.2%  
Price / Book Value ratio x4.70.6 779.1%  
Dividend payout %18.30-   
Avg Mkt Cap Rs m105,0902,477 4,242.0%   
No. of employees `000NANA-   
Total wages/salary Rs m6,22856 11,121.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m31,3084,211 743.6%  
Other income Rs m7079 89.3%   
Total revenues Rs m31,3784,289 731.6%   
Gross profit Rs m6,431569 1,131.0%  
Depreciation Rs m1,055204 515.9%   
Interest Rs m34430 7.9%   
Profit before tax Rs m5,41313 42,618.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-81-2 4,494.4%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,2046 19,729.5%   
Profit after tax Rs m4,1285 86,004.2%  
Gross profit margin %20.513.5 152.1%  
Effective tax rate %22.248.0 46.3%   
Net profit margin %13.20.1 11,566.4%  
BALANCE SHEET DATA
Current assets Rs m18,2476,852 266.3%   
Current liabilities Rs m11,2356,711 167.4%   
Net working cap to sales %22.43.3 668.9%  
Current ratio x1.61.0 159.1%  
Inventory Days Days86161 53.2%  
Debtors Days Days61318 19.3%  
Net fixed assets Rs m20,0353,673 545.5%   
Share capital Rs m377317 119.1%   
"Free" reserves Rs m21,8243,761 580.3%   
Net worth Rs m22,2014,078 544.5%   
Long term debt Rs m5,0001,671 299.3%   
Total assets Rs m39,41112,633 312.0%  
Interest coverage x160.21.0 15,560.1%   
Debt to equity ratio x0.20.4 55.0%  
Sales to assets ratio x0.80.3 238.3%   
Return on assets %10.63.4 306.7%  
Return on equity %18.60.1 15,795.5%  
Return on capital %19.77.7 257.1%  
Exports to sales %46.422.9 202.8%   
Imports to sales %10.514.3 73.5%   
Exports (fob) Rs m14,535964 1,507.8%   
Imports (cif) Rs m3,288602 546.3%   
Fx inflow Rs m14,722964 1,527.1%   
Fx outflow Rs m7,026607 1,157.3%   
Net fx Rs m7,696357 2,156.3%   
CASH FLOW
From Operations Rs m3,1241,345 232.3%  
From Investments Rs m-8,844-2,256 392.1%  
From Financial Activity Rs m5,026-1,200 -418.9%  
Net Cashflow Rs m-693-2,111 32.8%  

Share Holding

Indian Promoters % 74.1 4.5 1,635.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 0.0 -  
FIIs % 9.1 1.4 674.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 94.1 14.8%  
Shareholders   49,328 20,807 237.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   TTK HEALTHCARE  ALEMBIC LTD  WYETH LTD  ELDER PHARMA  SUVEN LIFE  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Recover; Healthcare & IT Stocks Witness Buying(12:30 pm)

Share markets in India have trimmed their early losses and are presently trading marginally lower. Sectoral indices are trading mixed with stocks.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 11 bn (up 42.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 42.6% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, ALEMBIC PHARMA has posted a net profit of Rs 904 m (up 42.6% YoY). Sales on the other hand came in at Rs 9 bn (up 33.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Dec 11, 2018 01:19 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS